Ocular Hypertension in Patients with Cataract
Keywords:
cataract, ocular hypertension, glaucomaAbstract
The crystalline lens is the natural lens of the eye located in the retroiridian space called the posterior chamber. Its function is to focus images coming from the outside onto the macula, which allows vision. The opacification of this lens is called cataract, which leads to a decrease in vision. Ocular hypertension occurs when intraocular pressure exceeds the normal value (average 21 mmHg) without signs of vision loss or optic nerve damage. If its increase is sustained over time, it causes damage to the optic nerve and leads to the development of glaucoma. Alterations in the morphology, position or metabolic changes of the lens cause alterations in the dynamics of the aqueous humor and lead to mechanical or obstructive alterations of the trabecular meshwork. The relationship between ocular hypertension and cataract is fundamental to advance the understanding of these ophthalmologic conditions, create treatment strategies and provide more effective and personalized care to patients, in addition to optimizing surgical procedures to improve visual outcomes. A review of the most relevant publications related to ocular hypertension in patients with cataract was performed in order to update knowledge on the subject.
Downloads
References
1. American Academy of Ophtalmology. Glaucoma (Basic and clinical Science Course 2014-2015). San Francisco: American Academy of Ophthalmology; 2014. [acceso 09/09/2024]. Disponible en: https://store.aao.org/basic-and-clinical-science-course-section-10-glaucoma.html
2. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. American journal of ophthalmology. 2000; 130:429-40. DOI: 10.1016/S0002-9394(00)00538-9
3. Leydhecker W, Akiyama K, Neumann HG. Der intraokular Druck gesunder menschlicher Augen [Intraocular pressure in normal human eyes]. Klin Monbl Augenheilkd Augenarztl Fortbild. 1958;133(5):662-70. German. PMID: 13621563.
4. Russell P, Koretz J, Epstein DL. Is primary open angle glaucoma caused by small proteins? Medical Hypotheses. 2018;41(5):445-58. DOI: 10.1016/0306-9877(93)90125-a
5. Population Reference Bureau. America’s Aging Population. 2011 [acceso 09/09/2024]. Disponible en: https://u.demog.berkeley.edu/~jrw/Biblio/Eprints/PRB/files/aging-in-america.pdf
6. Scott IU, Flynn HW. Retained lens fragments after cataract surgery. Ophthalmol Clin North Am. 2019;14(4):675-9. DOI: 10.1016/s0896-1549(05)70266-2
7. Choquet H, Paylakhi S, Kneeland S. A multiethnic genomewide association study of primary open angle glaucoma identifies novel risk loci. Nature Communications. 2018; 9:2278. DOI: 10.1038/s41467-018-04555-4
8. Hernández JR, Padilla CM, Barroso R, Rodríguez B. Epidemiología de la ceguera por cataratas y acciones para su prevención en Cuba. En: Hernández JR. Facoemulsificación. La Habana: Editorial Ciencias Médicas; 2022 [acceso 09/09/2024]. Disponible en: http://www.ecimed.sld.cu/2022/06/14/facoemulsificacion/
9. Kim HK. Decrease and conquer: Phacoemulsification technique for hard nucleus cataracts. Refract. Surg. 2009;35:1665-70. DOI: 10.1016/j.jcrs.2009.05.038
10. Chylack LT Jr, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, et al. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993;111(6):831-6. DOI: 10.1001/archopht.1993.01090060119035
11. Atalay E, Ourel T, Derici MK. The role of oxidative damage in cataract etiopathogenesis. Ther Adv Ophthalmol. 2023;15:25158414231168813. DOI: 10.1177/25158414231168813
12. Jick S, Beardsley T, Brasington C. 2019-2020 BCSC (Basic and Clinical Science Course), Section 11: Lens and Cataract Edition: American Academy of Ophthalmology; 2020 [acceso 10/09/2024]. Disponible en: https://www.aao.org/assets/9c6f2834-24c7-428a-a004-6f09048254a0/636312524130900000/bcsc1718-s11-pdf
13. J Li, Tripathi R, Tripathi B. Drug-induced ocular disorders. Drug Saf. 2008;31(2):127-41. DOI: 10.2165/00002018-200831020-00003
14. Chuck RS, Dunn SP, Flaxel CJ, Gedde SJ, Mah FS, Miller KM, et al. American Academy of Ophthalmology Preferred Practice Pattern Committee. Comprehensive Adult Medical Eye Evaluation Preferred Practice Pattern®. Ophthalmology. 2021;128(1): P1-P29. DOI: 10.1016/j.ophtha.2020.10.024
15. Caride F. Manual de facoemulsificación. 1ra ed. Argentina: Editorial Ediciones Journal SA; 2014; Capítulo II. p. 104-106.
16. Rodríguez B, Duarte N, Hormigó I, Méndez AM, García J, Palazuelos M. Calidad de vida relativa a la función visual en pacientes operados de catarata. Revista Cubana de Oftalmología. 2019 [acceso 09/09/2024];32(1). Disponible en: https://revoftalmologia.sld.cu/index.php/oftalmologia/article/view/698
17. Borras T. Gene expression in the trabecular meshwork and the influence of intraocular pressure. Prog Retin Eye Res. 2018;22:435-63 DOI: 10.1016/s1350-9462(03)00018-1
18. Gasull X, Ferrer E, Llobet A, Castellano A, Nicolas JM, Pales J, et al. Cell membrane stretch modulates the high-conductance Ca2+-activated K+ channel in bovine trabecular meshwork cells. Invest Ophthalmol Vis Sci;2003;44:706-14. DOI: 10.1167/iovs.02-0384
19. Bueno-Gimeno I, Gene-Sampedro A, Morales MC, España E. Influencia del error refractivo en la presión intraocular y en el espesor corneal central en una población de 6 a 17 años. Gaceta de optometría y óptica oftálmica. 2013 [acceso 09/09/2024];487. Disponible en: http://cgcoo.es/download.asp?file=media/gaceta/gaceta487/cientifico2.pdf
20. Topouzis F, Harris A. Risk factors por primary open-angle glaucoma and pseudoexfoliatuve glaucoma in the Thessaloniki eye Study. Am J Ophtalmol. 2018;152(2):219-28. DOI: 10.1016/j.ajo.2011.01.032
21. Sommer A. Glaucoma: Facts and fancies. Eye 1996;10:295-301. DOI: 10.1038/eye.1996.63
22. Cárdenas D, Sánchez L, Fernández L. Hipertensión ocular. En: Río M, Fernández L, Hernández JR, Ramos M. Oftalmología Diagnóstico y tratamiento. 2.a ed. La Habana: Editorial Ciencias Médicas; 2018. Capítulo IV. p. 104-6.
23. Kirwan C, O´Keefe M, Lanigan B. Corneal hysteresis and intraocular pressure measurement in children using the Reichert ocular response Analyzer. Am J Ophthalmol. 2021;142:990-2. DOI: 10.1016/j.ajo.2006.07.058
24. Chan C, Wiggs J, Sobrin L. The Genetic Influence on Corticosteroid Induced Ocular Hypertension: A Field Positioned for Discovery. American Journal of Ophthalmology. 2019;202:1-5. DOI: 10.1016/j.ajo.2019.02.001
25. Lopez JP, Sharon MDF. Central Corneal Thickness in Children and Adolescents with Pediatric Glaucoma and Eye Disorders at Risk of Developing Glaucoma Journal of Pediatric Ophthalmology & Strabismus. 2011;48(2):108-16. DOI: 10.3928/01913913-20100518-03
26. Ventura A, Bohnke M, Mojon D. Central corneal thickness measurements in patients with normal tension glaucoma, primary open angle glaucoma, pseudoexfoliation glaucoma, or ocular hypertension. British Journal of Ophthalmology. 2001;85:792-5. DOI: 10.1136/bjo.85.7.792
27. Gordon MO, Beiser JA, Brandt JD. The Ocular Hypertension Treatment Study; baseline factors that predict the onset of primary open-angle glaucoma. Arch Opththalmol. 2002;120:714-20 DOI: 10.1001/archopht.120.6.714
28. Conlon R, Saheb H, Ahmed IIK. Glaucoma treatment trends: a review. Can J Ophthalmol J Can Ophtalmol. 2017;52(1):114–24. DOI: 10.1016/j.jcjo.2016.07.013
29. Baek SU, Kwon S, Park IW, Suh W. Effect of Phacoemulsification on Intraocular Pressure in Healthy Subjects and Glaucoma Patients. J Korean Med Sci. 2019;34(6): e47. DOI: 10.3346/jkms.2019.34.e47
30. Masis M, Mineault PJ, Phan E, Lin SC. The role of phacoemulsification in glaucoma therapy: A systematic review and meta-analysis. Surv Ophthalmol. 2018;63(5):700–10. DOI: 10.1016/j.survophthal.2017.08.006
31. Veitía Z, Pérez E, Vidal M. Preoperatorio en la cirugía del cristalino. En: Río M, Fernández L, Hernández JR, Ramos M. Oftalmología Diagnóstico y tratamiento. 2 da ed. La Habana: Editorial Ciencias Médicas; 2018 [acceso 09/09/2024] Disponible en: http://www.ecimed.sld.cu/2019/06/05/oftalmologia-diagnostico-y-tratamiento-2da-ed/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Revista Cubana de Oftalmología
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
El contenido de la revista se encuentra accesible sin costo alguno. Está protegido por los términos de la Licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional
